1 BMC Psychiatry 2008 -1 8: 87
PMID 18992145
Title Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays.
Abstract Recent studies have shown similarities betweenschizophreniaand bipolar disorder in phenotypes and in genotypes, and those studies have contributed to an ongoing re-evaluation of the traditional dichotomy betweenschizophreniaand bipolar disorder. Bipolar disorder with psychotic features may be closely related toschizophreniaand therefore, psychosis may be an alternative phenotype compared to the traditional diagnosis categories.
We performed a cross-study analysis of 7 gene expression microarrays that include both psychosis and non-psychosis subjects. These studies include over 400 microarray samples (163 individual subjects) on 3 different Affymetrix microarray platforms.
We found that 110 transcripts are differentially regulated (p < 0.001) in psychosis after adjusting for confounding variables with a multiple regression model. Using a quantitative PCR, we validated a set of genes such as up-regulated metallothioneins (MT1E, MT1F, MT1H, MT1K,MT1X, MT2A and MT3) and down-regulated neuropeptides (SST, TAC1 and NPY) in the dorsolateral prefrontal cortex of psychosis patients.
这项研究表明cross-st的优点udy analysis in detecting consensus changes in gene expression across multiple microarray studies. Differential gene expression between individuals with and without psychosis suggests that psychosis may be a useful phenotypic variable to complement the traditional diagnosis categories.
SCZ Keywords schizophrenia, schizophrenic
2 J Psychiatr Res 2012 Nov 46: 1464-74
PMID 22954356
Title A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia.
Abstract Small cohort sizes and modest levels of gene expression changes in brain tissue have plagued the statistical approaches employed in microarray studies investigating the mechanism ofschizophrenia. To combat these problems a combined analysis of six prior microarray studies was performed to facilitate the robust statistical analysis of gene expression data from the dorsolateral prefrontal cortex of 107 patients withschizophreniaand 118 healthy subjects. Multivariate permutation tests identified 144 genes that were differentially expressed betweenschizophreniaand control groups. Seventy of these genes were identified as differentially expressed in at least one component microarray study but none of these individual studies had the power to identify the remaining 74 genes, demonstrating the utility of a combined approach. Gene ontology terms and biological pathways that were significantly enriched for differentially expressed genes were related to neuronal cell-cell signaling, mesenchymal induction, and mitogen-activated protein kinase signaling, which have all previously been associated with the etiopathogenesis ofschizophrenia. The differential expression of BAG3, C4B, EGR1,MT1X, NEUROD6, SST and S100A8 was confirmed by real-time quantitative PCR in an independent cohort using postmortem human prefrontal cortex samples. Comparison of gene expression betweenschizophrenicsubjects with and without detectable levels of antipsychotics in their blood suggests that the modulation ofMT1Xand S100A8 may be the result of drug exposure. In conclusion, this combined analysis has resulted in a statistically robust identification of genes whose dysregulation may contribute to the mechanism ofschizophrenia.
SCZ Keywords schizophrenia, schizophrenic
3 J Psychiatr Res 2012 Nov 46: 1464-74
PMID 22954356
Title A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia.
Abstract Small cohort sizes and modest levels of gene expression changes in brain tissue have plagued the statistical approaches employed in microarray studies investigating the mechanism ofschizophrenia. To combat these problems a combined analysis of six prior microarray studies was performed to facilitate the robust statistical analysis of gene expression data from the dorsolateral prefrontal cortex of 107 patients withschizophreniaand 118 healthy subjects. Multivariate permutation tests identified 144 genes that were differentially expressed betweenschizophreniaand control groups. Seventy of these genes were identified as differentially expressed in at least one component microarray study but none of these individual studies had the power to identify the remaining 74 genes, demonstrating the utility of a combined approach. Gene ontology terms and biological pathways that were significantly enriched for differentially expressed genes were related to neuronal cell-cell signaling, mesenchymal induction, and mitogen-activated protein kinase signaling, which have all previously been associated with the etiopathogenesis ofschizophrenia. The differential expression of BAG3, C4B, EGR1,MT1X, NEUROD6, SST and S100A8 was confirmed by real-time quantitative PCR in an independent cohort using postmortem human prefrontal cortex samples. Comparison of gene expression betweenschizophrenicsubjects with and without detectable levels of antipsychotics in their blood suggests that the modulation ofMT1Xand S100A8 may be the result of drug exposure. In conclusion, this combined analysis has resulted in a statistically robust identification of genes whose dysregulation may contribute to the mechanism ofschizophrenia.
SCZ Keywords schizophrenia, schizophrenic
Baidu